| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.12 | 0.6 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |